
Deallus Consulting sees new chief executive
pharmafile | July 17, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Claudio D’Ambrosio, consulting, deallus
Life sciences consultancy firm Deallus Consulting has confirmed its new chief executive is to be Dr Claudio D’Ambrosio.
D’Ambrosio succeeds Richard Withers, the founder and current chief executive who will remain on the board of Deallus Holdings.
D’Ambrosio joined Deallus in 2008 and took on his current position as head of North American Operations in 2011.
He says: “I am delighted to have the opportunity of leading Deallus Consulting through our next phase of growth. This is a really exciting time for the company as we continue on our growth trajectory and strive to cement our position as leaders in life science consulting.”
D’Ambrosio will report to Lawrence Hunt, chairman of Deallus Holdings who adds: “We are extremely excited about Claudio’s appointment. He brings a tremendous energy and a fresh approach to how we can achieve our vision and strategic imperatives and I have no doubt he is the right person to build on the success we have achieved under Richard’s leadership.”
Related Content
Medical Affairs at the Centre of Life Sciences Innovation
In today’s challenging business environment, many innovative life sciences companies are raising questions about the …






